Boston University Medical Campus |
More details on the funding opportunities listed below can be found at: Chris Bonner, Director of Corporate and Foundation Relations Sponsor: American Diabetes Association (ADA) Amount Available: $750,000+ The award is designed to assist outstanding assistant professor-level faculty investigators in conducting diabetes-related research. The award supports an individual's salary and research project to enable the investigator to advance his or her career as an independent investigator. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=2591&if=search Sponsor: American Diabetes Association (ADA) Amount Available: $360,000+ Grant Program: Junior Faculty Award These awards support new investigators who are establishing their independence in diabetes research. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=66610&if=search Grant Program: Basic Science Award These awards provide grant support to new and established investigators and to investigators who have not previously worked in the field of diabetes and have an imaginative proposal related to any aspect of diabetes research. Applications will be considered in any area that is relevant to the etiology or pathophysiology of diabetes and its complications. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=2590&if=search _____________________________________________________________ Amount Available: $100,000 Grant Program: Innovation Award Innovation Awards are intended to provide grant support to investigators who have creative and innovative proposals that hold significant promise for advancements in the prevention, cure, or treatment of diabetes. Early investigators and established investigators, including those who have not previously worked in the field of diabetes, are encouraged to apply. These awards are intended to support projects that 1) are high-risk, but have potential for high-impact results, 2) extend existing knowledge into a new area or application, and/or 3) utilize novel cross-disciplinary approaches. It is expected that an application for this award will generally lack significant preliminary data, however data supporting the feasibility of the proposed approach is encouraged. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=66611&if=search _____________________________________________________________ Amount Available: $600,000 Grant Program: Clinical/Translational Awards The awards are designed to support patient-oriented research in diabetes. For the purpose of this award, clinical research is defined as A) research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research as well as studies of normal physiology and mechanisms of disease and B) epidemiological research or other clinically based research COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=2592&if=search
_____________________________________________________________ Amount Available: $100,000 Grant Program: Macular Degeneration Standard Awards The standard award provides significant funding in the area of macular degeneration for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=40330&if=search Amount Available: $600,000 Grant Program: Target Identification in Lupus (TIL) Grants The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=61141&if=search Amount Available: up to $1,000,000 Grant Program: Detection of Human Growth Hormone Use The Partnership for Clean Competition (PCC) supports high-quality, high-impact, novel research that has a high likelihood of success and of resulting in methods or products that will advance the anti-doping field and ensure integrity in sport. Funded projects typically address the improvement of existing analytical methods for detecting particular drugs, the development of analytical methods to test for performance-enhancing drugs not currently detectable, and discovering cost effective approaches for testing widely abused substances across all levels of sport. The ongoing research priorities of the PCC can be found listed at http://www.cleancompetition.org/research-priorities.aspx. In an effort to address priority research areas to the PCC, the organization may motivate specific research topics by calling for requests for proposals. The PCC is currently requesting proposals for the topic, In an effort to address priority research areas to the PCC, the organization may motivate specific research topics by calling for requests for proposals. The PCC is currently requesting proposals for the topic, Detection of Human Growth Hormone Use Detection of Human Growth Hormone Use. Growth hormone (GH) is believed to be used by professional and amateur athletes as a performance-enhancing agent, yet its use in competitive sports is prohibited by the World Anti-Doping Agency (WADA). The PCC is requesting proposals for new and innovative approaches for detecting the use of human growth hormone COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=135720&if=search
_____________________________________________________________ Amount Available: up to $1,000,000 Grant Program: Detection of performance Enhancing Drugs (PEDs) Using Low Volume and The Partnership for Clean Competition (PCC) supports high-quality, high-impact, novel research that has a high likelihood of success and of resulting in methods or products that will advance the anti-doping field and ensure integrity in sport. Funded projects typically address the improvement of existing analytical methods for detecting particular drugs, the development of analytical methods to test for performance-enhancing drugs not currently detectable, and discovering cost effective approaches for testing widely abused substances across all levels of sport. The ongoing research priorities of the PCC can be found listed at http://www.cleancompetition.org/research-priorities.aspx. Deadlines: Pre-Application due July 1, 2012 COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=135722&if=search _____________________________________________________________ Sponsor: Helen Hay Whitney Foundation Amount Available: $147,000 Grant Program: Postdoctoral Research Fellowships The Foundation supports early postdoctoral research training in all basic biomedical sciences. To attain its ultimate goal of increasing the number of imaginative, well-trained and dedicated medical scientists, the Foundation grants financial support of sufficient duration to help further the careers of young men and women engaged in biological or medical research. The Foundation expects that fellowship training will be obtained in an academic setting. The selection of a commercial or industrial laboratory for the training experience is not acceptable. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=184&if=search
_____________________________________________________________ Amount Available: up to $1,000,000 The true test for new Alzheimer's drugs is in human clinical trials. Numerous treatments for Alzheimer's disease have been shown to be safe and to have some positive effect when tested in animal models of Alzheimer's disease. However, many of these potentially successful drugs have not been brought to human trials because of the increased cost and risk at this stage of research. The ADDF is responding to this problem by creating the Alzheimer's Program to Accelerate Clinical Trials (PACT). The goal of this Request for Proposals (RFP) is to increase the number of innovative drugs tested in humans for Alzheimer's disease. This program will fund biomarker-based pilot clinical trials for Alzheimer's disease. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=130523&if=search Amount Available: $150,000 Grant Program: National Innovative Research Grant (IRG) The objective of this grant is to support highly innovative, high-risk, high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research. Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. The Innovative Research Grant (IRG) promotes new ideas; therefore, proposals need not include preliminary data. However, a solid rationale for the work must be provided. Proposed work should not be the next logical step of previous work, but should have a high probability of revealing new avenues of investigation, if successful. This program aims to provide pilot or seed funding that should lead to successful competition for additional funding beyond the pilot period. The science focus is on research broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts. Proposals are encouraged from all basic disciplines as well as epidemiological, behavioral, community and clinical investigations that bear on cardiovascular and stroke problems. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=114201&if=search _____________________________________________________________ Amount Available: $154,000 The objective of this program is to encourage early career investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke while fostering new research in clinical and translational science, and encouraging community- and population-based activities. This grant does not fund basic science or support senior researchers, but encourages mentoring of early career investigators. Funding is available for research related to cardiovascular disease and stroke prevention or treatment, or to related clinical and public health problems, including multidisciplinary efforts. Proposals are encouraged on provider behavior, patient behavior, behavioral outcomes, risk factor outcomes, disease outcomes, cost benefit analyses, efforts to evaluate outcomes of patient care delivery and patient/provider and/or system compliance and adherence to recommendations, as well as pilot clinical research studies that may provide preliminary data for larger-scale investigation. Studies using existing databases are also encouraged. Ancillary studies or a clearly defined sub-study of an ongoing clinical research study are also encouraged. There must, however, be clear justification that the proposal is a sub-study and not a piece of an already funded project. COS: http://fundingopps.cos.com/cgi-bin/fo2/getRec?id=114200&if=search Amount Available: $400,000 Grant Program: Established Investigator Award To support mid-career investigators with unusual promise and an established record of accomplishments; candidates have a demonstrated commitment to cardiovascular or cerebrovascular science as indicated by prior publication history and scientific accomplishments. A candidate's career is expected to be in a rapid growth phase. Research broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts. Proposals are encouraged from all basic disciplines as well as epidemiological, behavioral, community and clinical investigations that bear on cardiovascular and stroke problems COS: none URL: http://my.americanheart.org/professional/Research/FundingOpportunities/ForScientists/Summer-2012---National-Established-Investigator-Award_UCM_321935_Article.jsp_____________________________________________________________
Office of the Associate Provost for Research
|